Emerald Advisers, LLC 13F Portfolio

CIK 1015083 Filing since Q1 2014 Q3 2026 filed Nov 9, 2026
Holdings as of Sep 30, 2026, from the 13F filed Nov 9, 2026.

Portfolio Snapshot

224 positions · Q3 2026

Emerald Advisers, LLC reported 224 positions worth $3.64B for the quarter ended Sep 30, 2026, down 14.3% on the prior quarter. It opened 15 new positions, added to 93, trimmed 100 and exited 28. Its largest holding is Travere Therapeutics, Inc. at 2.5% of the portfolio.

Portfolio Value
$3.64B
-14.3% QoQ · +21.6% YoY
Positions
224
15 new · 28 sold out
Top 10 Concentration
17.5%
of portfolio value
Largest Position
TVTX 2.5%
Travere Therapeutics, Inc.
Net Buying
-$16.20M
$383.52M bought · $399.73M sold
Turnover
9.7%
of the portfolio traded
Top Sector
Healthcare
27.2% of value
Track Record
50
quarters on file since Q1 2014

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Sector Allocation

10 sectors
27.18%
Healthcare
Healthcare27.18%
Technology26.38%
Industrials22.88%
Financial Services8.67%
Consumer Discretionary8.61%
Basic Materials2.77%
Energy1.48%
Consumer Staples1.12%
Real Estate0.896%
Utilities0.015%

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

HealthcareTechnologyIndustrialsFinancial ServicesConsumer DiscretionaryBasic MaterialsEnergyConsumer StaplesReal EstateUtilitiesCommunication ServicesOther

Largest Buys

Q3 2026
Holding Change Change % Trade Value Weight
PRAX Praxis Precision Medicines, Inc. +110.8K – $32.26M 0.886%
REPL Replimune Group, Inc. +2.04M – $27.03M 0.742%
RDVT Red Violet, Inc. +312.3K – $24.67M 0.677%
AXTI Axt Inc +312.2K – $24.17M 0.664%
FEIM Frequency Electronics Inc +279.4K – $23.61M 0.648%
NEO Neogenomics Inc +1.20M – $22.07M 0.606%
MXL Maxlinear, Inc +180.7K +64.5% $16.32M 1.14%
AEHR Aehr Test Systems +161.1K – $16.05M 0.441%
BTSG BrightSpring Health Services, Inc. +264.4K – $15.00M 0.412%
HRMY Harmony Biosciences Holdings, Inc. +351.3K – $13.79M 0.379%

Largest Sells

Q3 2026
Holding Change Change % Trade Value Weight
SYNA SYNAPTICS Inc -298.6K -100.0% $37.09M Exited
MOD Modine Manufacturing Co -194.6K -96.0% $36.44M 0.042%
RMBS Rambus Inc -252.7K -100.0% $33.54M Exited
TTMI Ttm Technologies Inc -219.2K -98.9% $26.92M <0.01%
MIR Mirion Technologies, Inc. -1.36M -100.0% $24.47M Exited
HIMS Hims & Hers Health, Inc. -608.5K -100.0% $21.10M Exited
CCB Coastal Financial Corp -216.3K -100.0% $16.77M Exited
ONTO Onto Innovation Inc. -54.2K -61.9% $16.69M 0.282%
GH Guardant Health, Inc. -90.4K -24.8% $16.12M 1.34%
VC Visteon Corp -162.4K -100.0% $16.11M Exited

New Positions

Q3 2026
Holding Shares Trade Value Weight
PRAX Praxis Precision Medicines, Inc. +110.8K $32.26M 0.886%
REPL Replimune Group, Inc. +2.04M $27.03M 0.742%
RDVT Red Violet, Inc. +312.3K $24.67M 0.677%
AXTI Axt Inc +312.2K $24.17M 0.664%
FEIM Frequency Electronics Inc +279.4K $23.61M 0.648%
NEO Neogenomics Inc +1.20M $22.07M 0.606%
AEHR Aehr Test Systems +161.1K $16.05M 0.441%
BTSG BrightSpring Health Services, Inc. +264.4K $15.00M 0.412%
HRMY Harmony Biosciences Holdings, Inc. +351.3K $13.79M 0.379%
SNEX StoneX Group Inc. +131.3K $8.49M 0.233%

Closed Positions

Q3 2026
Holding Shares Sold Trade Value Prior Weight
SYNA SYNAPTICS Inc -298.6K $37.09M 0.873%
RMBS Rambus Inc -252.7K $33.54M 0.789%
MIR Mirion Technologies, Inc. -1.36M $24.47M 0.576%
HIMS Hims & Hers Health, Inc. -608.5K $21.10M 0.497%
CCB Coastal Financial Corp -216.3K $16.77M 0.395%
VC Visteon Corp -162.4K $16.11M 0.379%
TREE LendingTree, Inc. -334.7K $14.82M 0.349%
AVEX AEVEX Corp. -538.6K $11.25M 0.265%
DFTX Definium Therapeutics, Inc. -178.8K $8.41M 0.198%
FLOC Flowco Holdings Inc. -382.1K $8.15M 0.192%
Holdings · Q3 2026

224 Positions

As ofSep 30, 2026
Value$3.64B
Top 1017.5%
Avg position$16.26M
# Activity
209 more holdings Create a free account to keep reading this institution’s full portfolio.
Showing 1–15 of 224 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at Emerald Advisers.

About Emerald Advisers, LLC’s 13F Portfolio

What are Emerald Advisers, LLC’s largest holdings?

As of its Q3 2026 13F filing, Emerald Advisers, LLC’s five largest positions were Travere Therapeutics, Inc. (TVTX) at 2.5%, Corcept Therapeutics Inc (CORT) at 2.4%, InterDigital, Inc. (IDCC) at 2.0%, Sensient Technologies Corp (SXT) at 1.7%, Cohu Inc (COHU) at 1.6% of the reported portfolio.

How much is Emerald Advisers, LLC’s portfolio worth?

Emerald Advisers, LLC reported a 13F portfolio worth $3.64B across 224 positions for Q3 2026. That is down 14.3% from the previous quarter.

What did Emerald Advisers, LLC buy in Q3 2026?

Its largest purchases by value were Praxis Precision Medicines, Inc. ($32.26M), Replimune Group, Inc. ($27.03M), Red Violet, Inc. ($24.67M). It opened 15 new positions.

What did Emerald Advisers, LLC sell in Q3 2026?

Its largest sales by value were SYNAPTICS Inc ($37.09M), Modine Manufacturing Co ($36.44M), Rambus Inc ($33.54M). It exited 28 positions entirely.

Where does this data come from?

From the Form 13F-HR reports Emerald Advisers, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.